now your saying they are doing phase 2. You were fighting with me for days saying they arnt doing any in human trials for the next 10 years and need multiple phase trials and years of waiting and the company is worthless.
Hawk70 you keep on avoiding the question why was MSB a 350 million market cap on preclinical studies results? Also why was AGN a 100 million market cap on preclinical studies results? Answer me hurry up
The answer to the above is your a troll
now your saying they are doing phase 2. You were fighting with...
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.91M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 6.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 300 | 1 |
View Market Depth
| Last trade - 16.12pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.9¢ |
Change
0.000 ( 2.82 %) |
||||
| Open | High | Low | Volume | ||
| 6.9¢ | 6.9¢ | 6.9¢ | 15000 | ||
| Last updated 15.16pm 07/06/2024 ? | |||||
| NYR (ASX) Chart |
Day chart unavailable